(Q36719978)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17257863%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

review article

1 reference

title

Management of oral epithelial dysplasia: a review (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17257863%20AND%20SRC:MED&resulttype=core&format=json

oral epithelial dysplasia

24 December 2019

main subject

1 reference

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17257863%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

Martin Thornhill

18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17257863%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

Saman Warnakulasuriya

19

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17257863%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

author name string

Michael Brennan

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17257863%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

Cesar A Migliorati

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17257863%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

Peter B Lockhart

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17257863%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

David Wray

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17257863%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

Ibtisam Al-Hashimi

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17257863%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

Tony Axéll

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17257863%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

Alison J Bruce

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17257863%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

William Carpenter

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17257863%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

Ellen Eisenberg

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17257863%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

Joel B Epstein

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17257863%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

Palle Holmstrup

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17257863%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

Mats Jontell

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17257863%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

Howell Sasser

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17257863%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

Mark Schifter

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17257863%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

Bud Silverman

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17257863%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

Kobkan Thongprasom

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17257863%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

Isaäc van der Waal

20

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17257863%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

publication date

25 January 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17257863%20AND%20SRC:MED&resulttype=core&format=json

Oral Surgery Oral Medicine Oral Pathology Oral Radiology and Endodontics

24 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17257863%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

volume

103 Suppl

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17257863%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

page(s)

S19.e1-12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17257863%20AND%20SRC:MED&resulttype=core&format=json

Prognosis of oral pre-malignant lesions: significance of clinical, histopathological, and molecular biological characteristics

24 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2006.10.015

Chemoprevention of oral leukoplakia with vitamin A and beta carotene: an assessment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2006.10.015

Long-term treatment outcome of oral premalignant lesions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2006.10.015

Observer variability in the histologic assessment of oral premalignant lesions.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2006.10.015

Intraexaminer and interexaminer reliability in the diagnosis of oral epithelial dysplasia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2006.10.015

Observer agreement in the grading of oral epithelial dysplasia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2006.10.015

Identification of genes and molecular pathways involved in the progression of premalignant oral epithelia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2006.10.015

Accumulative increase of loss of heterozygosity from leukoplakia to foci of early cancerization in leukoplakia of the oral cavity.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2006.10.015

Changes in apoptosis and mitotic index, p53 and Ki67 expression in various types of oral leukoplakia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2006.10.015

Histopathological and immunohistochemical study of malignant transformation of oral leukoplakia, with special reference to apoptosis-related gene products and proliferative activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2006.10.015

Two-phase appearance of oral epithelial dysplasia resulting from focal proliferation of parabasal cells and apoptosis of prickle cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2006.10.015

Senescing oral dysplasias are not immortalized by ectopic expression of hTERT alone without other molecular changes, such as loss of INK4A and/or retinoic acid receptor-β: but p53 mutations are not necessarily required

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2006.10.015

Immunohistochemical study of syndecan-1 down-regulation and the expression of p53 protein or Ki-67 antigen in oral leukoplakia with or without epithelial dysplasia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2006.10.015

Flow cytometric analysis of nuclear DNA content in oral leukoplakia: relation to clinicopathologic findings

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2006.10.015

Flow cytometric analysis of cell cycle fractions in oral leukoplakia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2006.10.015

Chromosomal aneuploidy precedes morphological changes and supports multifocality in head and neck lesions.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2006.10.015

Flow cytometric analysis of nuclear DNA content in oral leukoplakia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2006.10.015

Overexpression of matrix metalloproteinase-1 and -9 mRNA is associated with progression of oral dysplasia to cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2006.10.015

Increased EMMPRIN (CD 147) expression during oral carcinogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2006.10.015

Stromelysin 3, Ets-1, and vascular endothelial growth factor expression in oral precancerous and cancerous lesions: correlation with microvessel density, progression, and prognosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2006.10.015

Differential expression of the keratin-4, -13, -14, -17 and transglutaminase 3 genes during the development of oral squamous cell carcinoma from leukoplakia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2006.10.015

Expression of alpha(v)beta6 integrin in oral leukoplakia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2006.10.015

Expression of CD44s, CD44v5, CD44v6 and CD44v7-8 in betel quid chewing-associated oral premalignant lesions and squamous cell carcinomas in Taiwan

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2006.10.015

Evaluation of TGF-alpha and EGFR expression in oral leukoplakia and oral submucous fibrosis by quantitative immunohistochemistry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2006.10.015

Frequent allelic imbalances at 8p and 11q22 in oral and oropharyngeal epithelial dysplastic lesions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2006.10.015

Allelic imbalance at chromosomal loci implicated in the pathogenesis of oral precancer, cumulative loss and its relationship with progression to cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2006.10.015

Cytologic and DNA-cytometric very early diagnosis of oral cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2006.10.015

Alterations of rb pathway components are frequent events in patients with oral epithelial dysplasia and predict clinical outcome in patients with squamous cell carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2006.10.015

Dysregulated cyclin D1 expression early in head and neck tumorigenesis: in vivo evidence for an association with subsequent gene amplification

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2006.10.015

Relationship of p53 overexpression to other cell cycle regulatory proteins in oral squamous cell carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2006.10.015

Frequent inactivation of p16INK4a in oral premalignant lesions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2006.10.015

Potential diagnostic use of p16INK4A, a new marker that correlates with dysplasia in oral squamoproliferative lesions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2006.10.015

Interventions for treating oral leukoplakia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2006.10.015

Topical bleomycin treatment of oral leukoplakia: a randomized double-blind clinical trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2006.10.015

Acitretin and treatment of the oral leucoplakias. A model to have an active molecules release

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2006.10.015

13-cis-retinoic acid in the treatment of oral leukoplakia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2006.10.015

The chemopreventive effects of tea on human oral precancerous mucosa lesions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2006.10.015

bcl-2 expression and apoptotic bodies in 13-cis-retinoic acid (isotretinoin)-topically treated oral leukoplakia: a pilot study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2006.10.015

Oral proliferative verrucous leukoplakia (PVL); open trial of surgery compared with combined therapy using surgery and methisoprinol in papillomavirus-related PVL.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2006.10.015

Efficacy of oral lycopene in the treatment of oral leukoplakia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2006.10.015

Randomized, double-blind, placebo-controlled phase IIb trial of the cyclooxygenase inhibitor ketorolac as an oral rinse in oropharyngeal leukoplakia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2006.10.015

Cytologic and DNA-cytometric follow-up of oral leukoplakia after CO2- and Er:YAG-laser assisted ablation: a pilot study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2006.10.015

Comparison of electrodessication with CO2 laser for the treatment of actinic cheilitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2006.10.015

The use of CO2 laser in the treatment of oral white patches: outcomes and factors affecting recurrence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2006.10.015

Evaluation of surgical excision of non-homogeneous oral leukoplakia in a screening intervention trial, Kerala, India

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2006.10.015

The results of CO2 laser surgery in patients with oral leukoplakia: a 25 year follow up.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2006.10.015

Response of oral leukoplakias to the administration of vitamin A

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2006.10.015

Successful treatment of oral verrucous hyperplasia with topical 5-aminolevulinic acid-mediated photodynamic therapy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2006.10.015

Photodynamic therapy (PDT) using topically applied delta-aminolevulinic acid (ALA) for the treatment of oral leukoplakia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2006.10.015

Selection of topically applied non-steroidal anti-inflammatory drugs for oral cancer chemoprevention

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2006.10.015

An attenuated adenovirus, ONYX-015, as mouthwash therapy for premalignant oral dysplasia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2006.10.015

Lack of molecular markers to predict malignant potential of oral precancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2006.10.015

Toluidine blue staining identifies high-risk primary oral premalignant lesions with poor outcome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2006.10.015

Toluidine blue uptake in potentially malignant oral lesions in vivo: clinical and histological assessment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2006.10.015

An audit of the efficacy of the oral brush biopsy technique in a specialist Oral Medicine unit

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2006.10.015

Fluorescence spectroscopy combined with 5-aminolevulinic acid-induced protoporphyrin IX fluorescence in detecting oral premalignancy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2006.10.015

Assessment of oral premalignancy using elastic scattering spectroscopy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2006.10.015

Potentially malignant lesions and conditions of the mouth and oropharynx: natural history--cellular and molecular markers of risk.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2006.10.015

Oral leukoplakia: a proposal for uniform reporting

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2006.10.015